Bapineuzumab (Anti-Amyloid Beta) (A3111-GRP)

Bapineuzumab (Anti-Amyloid Beta) is a monoclonal antibody targeting β-amyloid protein (APP). It can be used for the research of Alzheimer’s disease (AD). MW :140.16 KD.